Login
Israel-Hamas Conflict
Donald Trump
NATO
Military
Artificial Intelligence
Israel-Iran Conflict
Iran Politics
Heatwaves
Airstrike
Middle East Politics
US Foreign Policy
NBA
Social Media
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • Updated

Alzheimer's: Real-world data shows lecanemab side effects are rare

Summary by Medical News Today
Significant adverse events — such as ARIA — with lecanemab, the drug that slows Alzheimer's, is rare and manageable, “real-world” data from people with mild Alzheimer's disease shows.

1 Articles

All
Left
1
Center
Right
Medical News TodayMedical News Today
Lean Left

Alzheimer's: Real-world data shows lecanemab side effects are rare

Significant adverse events — such as ARIA — with lecanemab, the drug that slows Alzheimer's, is rare and manageable, “real-world” data from people with mild Alzheimer's disease shows.

·United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Medical News Today broke the news in United States on Friday, May 16, 2025.
Sources are mostly out of United States (1)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Alzheimer's Disease icon

Alzheimer's Disease

You have read 3 out of your 5 free daily articles.

Our use of cookies
Unlike other news sites, we do not share or sell your data to third-parties for targeted ads.
By continuing to use our application or website, you agree to our Terms of Service and Privacy Policy.
News
For You
SearchBlindspotLocal